Indicates growing incidence of cancer among Indian population; five out of top 20 new brand launches are cancer drugs ...

Policy Exchange attacks repeal of parts of Tories' Legacy Act, which removes a block on people like Gerry Adams seeking ...

The tech billionaires who attended the inauguration of President Donald J. Trump are not the oligarchs seen in Russia or ...

The cost of dealing with Northern Ireland’s troubled past is set to be considerably more than £2 billion, a UK think tank has ...

A coroner overseeing the inquest of a woman who died following a Covid vaccine has stood down amid claims of bias and ...

The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...

Goldman Sachs updated its price target on AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN) shares to GBP150.67, down from GBP155.58, while reaffirming a Buy rating on the stock. The adjustment follows a ...

Adding fluorine to drug molecules can be tricky, but is often worthwhile. Rachel Brazil talks to the chemists trying to tame ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Cadrenal Therapeutics, a biopharmaceutical company listed on the Nasdaq under the ticker symbol CVKD, made a public announcement of leadership changes through an 8-K SEC filing on February 4, 2025.

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...